Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia

D. Araja; U. Berkis; A. Lunga; M. Murovska

Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia

D. Araja, U. Berkis, A. Lunga, M. Murovska

Rīga Stradiņš University

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S45
Number of pages	1
Journal	Value in Health
Volume	25
Issue number	1
Publication status	Published - Jan 2022
Event	Virtual ISPOR Europe 2021 - Emerging Frontiers and Opportunities: Special Populations and Technologies - Copenhagen, Denmark Duration: 30 Nov 2021 → 3 Dec 2021

Keywords*

ME/CFS
Direct costs
Latvia

Field of Science*

3.2 Clinical medicine
3.3 Health sciences
5.2 Economy and Business

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{80ce0dda49584f649c19983b70899b0b,

title = "Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia",

keywords = "ME/CFS, Direct costs, Latvia",

author = "D. Araja and U. Berkis and A. Lunga and M. Murovska",

year = "2022",

month = jan,

language = "English",

volume = "25",

pages = "S45",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "1",

note = "Virtual ISPOR Europe 2021 - Emerging Frontiers and Opportunities: Special Populations and Technologies, Virtual ISPOR Europe 2021 ; Conference date: 30-11-2021 Through 03-12-2021",

}

TY - JOUR

T1 - Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia

AU - Araja, D.

AU - Berkis, U.

AU - Lunga, A.

AU - Murovska, M.

PY - 2022/1

Y1 - 2022/1

KW - ME/CFS

KW - Direct costs

KW - Latvia

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000746490200196

M3 - Meeting Abstract

SN - 1098-3015

VL - 25

SP - S45

JO - Value in Health

JF - Value in Health

IS - 1

T2 - Virtual ISPOR Europe 2021 - Emerging Frontiers and Opportunities: Special Populations and Technologies

Y2 - 30 November 2021 through 3 December 2021

ER -

Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia

Keywords*

Field of Science*

Publication Type*

UN SDGs

Other files and links

Selection of biomarkers in ME/CFS for patient stratification and treatment surveillance / optimisation

Cite this

Direct costs of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Latvia

Keywords*

Field of Science*

Publication Type*

UN SDGs

Other files and links

Projects

Selection of biomarkers in ME/CFS for patient stratification and treatment surveillance / optimisation

Cite this